Stock Scorecard



Stock Summary for Stryker Corp (SYK) - $354.82 as of 12/23/2025 8:54:01 PM EST

Total Score

8 out of 30

Safety Score

52 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for SYK

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SYK

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SYK

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SYK

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for SYK (52 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for SYK

Is Boston Scientific Corp. (BSX) Positioned for Solid, Durable Growth? 12/23/2025 8:05:00 AM
Does Becton Dickinson’s Recent Slide Create an Opportunity for Long Term Investors in 2025? 12/22/2025 8:20:00 PM
Citi Cuts Stryker (SYK) PT, Maintains Buy Amid Leadership Changes 12/22/2025 3:09:00 PM
CCLA Investment Management Has $141.98 Million Position in Stryker Corporation $SYK 12/22/2025 10:09:00 AM
Citi Cuts Stryker (SYK) PT, Maintains Buy Amid Leadership Changes 12/22/2025 9:53:00 AM
11 Best Healthcare AI Stocks to Buy Now 12/21/2025 10:23:00 AM
EDAP TMS S.A.'s (NASDAQ:EDAP) Price Is Right But Growth Is Lacking After Shares Rocket 32% 12/21/2025 8:09:00 AM
Rep. Thomas H. Kean, Jr. Sells Stryker Corporation (NYSE:SYK) Stock 12/20/2025 7:10:00 AM
How Investors Are Reacting To Zimmer Biomet (ZBH) Dividend Move And OneStep Digital Recovery Partnership 12/19/2025 10:41:00 PM
Is It Too Late To Consider Stryker After Its Robotics Expansion And Strong Share Gains? 12/19/2025 7:08:00 PM

Financial Details for SYK

Company Overview

Ticker SYK
Company Name Stryker Corp
Country N/A
Description Stryker Corporation (SYK) is a leading global medical technology firm headquartered in Kalamazoo, Michigan, renowned for its innovative solutions that elevate patient care and surgical outcomes. The company boasts a diverse portfolio encompassing joint replacement implants, surgical instruments, and cutting-edge navigation systems across various medical specialties, including orthopedics and neurosurgery. With a strong focus on technological advancement and an unwavering commitment to enhancing healthcare delivery, Stryker is strategically positioned to capitalize on growth opportunities within the expanding medical device market, making it an attractive investment for institutional investors seeking stability and innovation in the healthcare sector.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date 1/27/2026

Stock Price History

Last Day Price 354.82
Price 4 Years Ago 257.24
Last Day Price Updated 12/23/2025 8:54:01 PM EST
Last Day Volume 901,980
Average Daily Volume 1,791,052
52-Week High 403.95
52-Week Low 327.71
Last Price to 52 Week Low 8.27%

Valuation Measures

Trailing PE N/A
Industry PE 32.56
Sector PE 120.50
5-Year Average PE 30.26
Free Cash Flow Ratio 41.69
Industry Free Cash Flow Ratio 15.92
Sector Free Cash Flow Ratio 30.70
Current Ratio Most Recent Quarter 1.85
Total Cash Per Share 8.51
Book Value Per Share Most Recent Quarter 56.97
Price to Book Ratio 6.20
Industry Price to Book Ratio 4.84
Sector Price to Book Ratio 56.47
Price to Sales Ratio Twelve Trailing Months 5.57
Industry Price to Sales Ratio Twelve Trailing Months 4.92
Sector Price to Sales Ratio Twelve Trailing Months 25.45
Analyst Buy Ratings 13
Analyst Strong Buy Ratings 7

Share Statistics

Total Shares Outstanding 382,424,000
Market Capitalization 135,691,683,680
Institutional Ownership N/A

Dividends

Ex-Dividend Date 12/31/2025
Previous Dividend Amount 0.8400
Current Dividend Amount 0.8800
Total Years Dividend Increasing Dividend Contender - Increasing for 15 Years
Trailing Annual Dividend Rate 3.36
Trailing Annual Dividend Yield 0.94%
Forward Annual Dividend Rate 3.52
Forward Annual Dividend Yield 0.99%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 0.96%
5-Year Average Dividend Yield 1.02%
1-Year Dividend Growth Rate Percentage 4.94%
3-Year Dividend Growth Rate Percentage 5.58%
5-Year Dividend Growth Rate Percentage 7.09%
All-Time Dividend Growth Rate Percentage 11.89%
Dividend Payout Ratio 44.21%

Income Statement

Quarterly Earnings Growth YOY 2.80%
Annual Earnings Growth -5.43%
Reported EPS 12 Trailing Months 7.60
Reported EPS Past Year 9.16
Reported EPS Prior Year 12.19
Net Income Twelve Trailing Months 2,943,000,000
Net Income Past Year 2,993,000,000
Net Income Prior Year 3,165,000,000
Quarterly Revenue Growth YOY 10.20%
5-Year Revenue Growth 8.71%
Operating Margin Twelve Trailing Months 22.30%

Balance Sheet

Total Cash Most Recent Quarter 3,256,000,000
Total Cash Past Year 3,652,000,000
Total Cash Prior Year 2,971,000,000
Net Cash Position Most Recent Quarter -11,589,000,000
Net Cash Position Past Year -8,536,000,000
Long Term Debt Past Year 12,188,000,000
Long Term Debt Prior Year 10,901,000,000
Total Debt Most Recent Quarter 14,845,000,000
Equity to Debt Ratio Past Year 0.63
Equity to Debt Ratio Most Recent Quarter 0.59
Total Stockholder Equity Past Year 20,634,000,000
Total Stockholder Equity Prior Year 18,593,000,000
Total Stockholder Equity Most Recent Quarter 21,785,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 4,073,000,000
Free Cash Flow Per Share Twelve Trailing Months 10.65
Free Cash Flow Past Year 3,487,000,000
Free Cash Flow Prior Year 3,136,000,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 347.59
20-Day Bollinger Middle Band 371.81
20-Day Bollinger Upper Band 396.02
Beta 0.90
RSI 0.00
50-Day SMA 375.02
150-Day SMA 333.29
200-Day SMA 305.89

System

Modified 12/23/2025 8:59:03 AM EST